Absorica (Ranbaxy Laboratories Inc.)
Welcome to the PulseAid listing for the Absorica drug offered from Ranbaxy Laboratories Inc.. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Ranbaxy Laboratories Inc. |
| NON-PROPRIETARY NAME: | isotretinoin |
| SUBSTANCE NAME: | ISOTRETINOIN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Retinoid [EPC],Retinoids [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-06-08 |
| END MARKETING DATE: | 0000-00-00 |
Absorica HUMAN PRESCRIPTION DRUG Details:
| Item Description | Absorica from Ranbaxy Laboratories Inc. |
| LABELER NAME: | Ranbaxy Laboratories Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 10(mg/1) |
| START MARKETING DATE: | 2012-06-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 10631-115_83c5bc5c-9073-4903-9bda-a3452e6ddac6 |
| PRODUCT NDC: | 10631-115 |
| APPLICATION NUMBER: | NDA021951 |
Other ISOTRETINOIN Pharmaceutical Manufacturers / Labelers:
